Fundraising FoxHuman Longevity
San Diego, US · Delaware corporation · 2 known investors
Find your way into Human Longevity
Sign up to see every warm intro you have to Human Longevity
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Human Longevity team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
DK
David KarowExecutive
Board
WH
Wei-Wu HeBoard director
JH
James HuangBoard director
HS
Helmut SchuehslerBoard director
Investors · 2
Silver Lake Partnerslisted by Silver Lake PartnersMenlo Park
How we know: Silver Lake Partners's portfolio page · Not right? Tell us
GE VenturesreportedCincinnati
How we know: offering press articles · open dataset · 5k.vc investor directory · Not right? Tell us
Funding
SEC filings, press & company announcements$59M disclosed across 3 of 4 rounds · 2019–2024
- Undisclosed amountSeries BAug 2024Source ↗
▶$32MraisedAug 2024 · 18 investors · BiotechnologyRule 506(b)
▶$32MraisedAug 2024 · 18 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Wei-Wu HeDirector
- James HuangDirector
- Helmut SchuehslerDirector
- David KarowExecutive Officer, Director
- James HuExecutive Officer, Director
- Offering amount
- $32M
- Amount sold
- $32M
- First sale
- Mar 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.9MraisedOct 2022 · 11 investors · BiotechnologyRule 506(b)
▶$6.9MraisedOct 2022 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Wei-Wu HeDirector
- David KarowExecutive Officer, Director
- James HuExecutive Officer, Director
- Offering amount
- $11.7M
- Amount sold
- $6.9M
- First sale
- Sep 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$20.1MraisedJul 2019 · 1 investors · BiotechnologyRule 506(b)
▶$20.1MraisedJul 2019 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David KarowExecutive Officer, Director
- Wei-Wu HeDirector
- James HuDirector
- Offering amount
- $30M
- Amount sold
- $20.1M
- First sale
- Jun 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Human Longevity's investors?
- Human Longevity's investors include Silver Lake Partners, GE Ventures.
- How much funding has Human Longevity raised?
- Human Longevity has disclosed $59M raised across 3 of its 4 known rounds.
- Where is Human Longevity headquartered?
- Human Longevity is headquartered in San Diego, US.